{
  "page": [
    {
      "title": "Elevens Title",
      "description": "Elevens description. Elevens description. Elevens description. Elevens description. Elevens description.  ",
      "shareImage": "/images/social/default.webp"
    }
  ],
  "headings": [
    {
      "id": 1,
      "title": "Our vision",
      "subhead": "Elevens is a healthcare AI advisory of the leading physicians, scientists, engineers and entrepreneurs in healthcare AI."
    },
    {
      "id": 2,
      "title": "Leading you there",
      "subhead": "We define the path forward for leading companies building the future of digital health and clinical machine learning."
    }
  ],
  "chart": [
    {
      "id": 1,
      "label": "PRE-SEED",
      "backgroundColor": "hsl(320, 25%, 30%)",
      "height": 100
    },
    {
      "id": 2,
      "label": "SEED",
      "backgroundColor": "hsl(300, 25%, 30%)",
      "height": 100
    },
    {
      "id": 3,
      "label": "SERIES A",
      "backgroundColor": "hsl(280, 25%, 30%)",
      "height": 100
    },
    {
      "id": 4,
      "label": "SERIES B",
      "backgroundColor": "hsl(260, 25%, 30%)",
      "height": 100
    },
    {
      "id": 5,
      "label": "SERIES C",
      "backgroundColor": "hsl(240, 25%, 30%)",
      "height": 100
    },
    {
      "id": 6,
      "label": "MEZZANINE",
      "backgroundColor": "hsl(220, 25%, 30%)",
      "height": 100
    },
    {
      "id": 7,
      "label": "PUBLIC",
      "backgroundColor": "hsl(200, 25%, 30%)",
      "height": 100
    }
  ],
  "content": [
    {
      "id": 1,
      "title": "PRE-SEED",
      "text": "<p>Investing in startups that specialize in healthcare technology during their pre-seed stage entails navigating a range of challenges and uncertainties. One of the most significant obstacles is the absence of a fully-developed product or service, which is a common feature of early-stage startups. This intrinsic uncertainty can create difficulties for investors when it comes to assessing the potential for success and returns on their investment. Furthermore, pre-seed startups often have limited financial resources and heavily rely on funding to bring their product or service to life. As a result, investors must conduct a thorough assessment of the startup's business model, market potential, and management team to determine if it represents a viable investment opportunity.</p><h4>Practice Areas</h4><ul><li>Prototype-to-market fit adjustment</li><li>Human Assets and capabilities needs assessment</li><li>Market sizing</li><li>Competitive landscape assessment</li><li>Funding assessment to get to Seed</li><li>Seed funding introductions</li></ul>",
      "backgroundColor": "hsl(320, 25%, 30%)"
    },
    {
      "id": 2,
      "title": "SEED",
      "text": "<p>When considering investing in a seed-stage healthcare technology startup, investors may have a host of concerns. Foremost among these concerns is the high level of uncertainty commonly associated with early-stage ventures. These startups frequently lack a fully-developed product or service, making it challenging to evaluate their potential for success or the likelihood of generating returns on investment. Furthermore, seed-stage healthcare technology startups may have limited financial resources and require significant investment to bring their product to market. Investors must also consider factors such as regulatory hurdles, competitive landscape, and potential market demand for the startup's offering. As a result, it is crucial for investors to conduct a comprehensive evaluation of a variety of factors before making a decision to invest in a seed-stage healthcare technology startup.</p><h4>Practice Areas</h4><ul><li>Product-to-market fit adjustment</li><li>Market focus</li><li>Revenue modeling</li><li>IP portfolio management</li><li>Product development</li><li>Early evangelical selling</li><li>Financial partnership development</li></ul>",
      "backgroundColor": "hsl(300, 25%, 30%)"
    },
    {
      "id": 3,
      "title": "SERIES A",
      "text": "<p>When evaluating a Series A stage startup, investors have unique concerns that differ from those investing in earlier stages. Despite the startup developing a product or service, uncertainties regarding its market potential and scalability may persist. As such, investors require evidence of traction and revenue growth, along with a robust business plan and capable leadership team. Additionally, investors may worry about competition and potential threats to the startup's market position. Furthermore, it is essential for investors to ensure that the startup has a clear path to profitability and that the capital raised will be utilized effectively to drive growth and generate returns on investment.</p><h4>Practice Areas</h4><ul><li>Market execution</li><li>Revenue base development</li><li>Product development</li><li>Scaling sales</li><li>Market messaging and communications</li><li>Financial partnership development</li><li>Best practices for acquirability</li></ul>",
      "backgroundColor": "hsl(280, 25%, 30%)"
    },
    {
      "id": 4,
      "title": "SERIES B",
      "text": "<p>When investing in a Series B stage startup, investors may have distinct concerns compared to earlier stage investors. By this stage, the startup has likely developed its product or service and is generating revenue. However, investors may worry about the scalability of the business and its potential for sustainable growth. They may also want to know how the startup plans to remain competitive in a crowded market. Moreover, investors may seek assurance that the startup has a solid management team and a clear growth strategy, and they may evaluate its financial performance to date and future projections. Ultimately, Series B investors aim to ensure the startup has a clear path to sustained growth and profitability.</p><h4>Practice Areas</h4><ul><li>Product manufacturing</li><li>Service scaling</li><li>Market growth</li><li>Scaling sales to next level</li><li>Performance metrics development</li><li>Expert validation and analyst coverage</li><li>Financial partnership development</li><li>Liquidity options development</li></ul>",
      "backgroundColor": "hsl(260, 25%, 30%)"
    },
    {
      "id": 5,
      "title": "SERIES C",
      "text": "<p>Investors at the Series C funding stage of a healthcare technology startup have distinct concerns from those investing in earlier stages. At this point, the startup should have a well-established product or service, a track record of revenue generation, and a loyal customer base. Nevertheless, investors may still be apprehensive about the startup's ability to maintain its growth trajectory and scale its operations. They may also want to evaluate the competitive landscape and any potential barriers to entry. </p><p>Scrutinizing the startup's management team and its ability to manage growth and navigate regulatory hurdles is essential. Additionally, investors may closely examine the financials, including cash flow, burn rate, and profitability. Ultimately, Series C investors aim to ensure that the healthcare technology startup has a clear path to long-term sustainability, growth, and profitability.</p><h4>Practice Areas</h4><ul><li>Product portfolio expansion</li><li>New market development</li><li>Scaling sales to next level</li><li>Profitability</li><li>Liquidity options development</li></ul>",
      "backgroundColor": "hsl(240, 25%, 30%)"
    },
    {
      "id": 6,
      "title": "MEZZANINE",
      "text": "<p>At the mezzanine funding stage, healthcare technology startups typically aim to scale up operations and broaden market reach. Nevertheless, investors may harbor reservations at this funding juncture. Investors may question if the startup possesses a viable trajectory toward profitability and sustainable growth. Investors will require proof that the company's products or services cater to market demand while adhering to a sustainable business model. In addition, investors will scrutinize the management team's track record of successful execution and the ability to adapt to evolving market conditions. Regulatory compliance and risk management measures must also be in place. Lastly, investors will seek a clear exit strategy to ensure a reasonable return on investment. Ultimately, investors targeting healthcare technology startups at the mezzanine funding stage will pursue a well-rounded investment opportunity that balances growth potential with a sturdy business foundation.</p><h4>Practice Areas</h4><ul><li>Major event financing</li><li>Merger and acquisition options development</li><li>Liquidity option focus</li></ul>",
      "backgroundColor": "hsl(220, 25%, 30%)"
    },
    {
      "id": 7,
      "title": "PUBLIC",
      "text": "<p>It is imperative that investors seeking to finance a healthcare technology startup at the IPO funding level remain cognizant of a distinct set of considerations. The company's shift from a privately held entity to a publicly traded one warrants a heightened level of scrutiny and accountability. Therefore, investors must prioritize ensuring that the company exhibits a proven record of revenue growth and profitability.</p><p>Investors will conduct an in-depth assessment of the company's financial statements to identify a sustained revenue growth trend and a clear path to profitability. Additionally, investors will scrutinize the company's products or services to ascertain if they hold a competitive advantage in the market. Moreover, investors will evaluate the strength of the company's intellectual property portfolio to safeguard its innovations.</p><p>Lastly, investors will anticipate a well-defined vision and strategy from the management team, accompanied by a comprehensive plan to utilize the IPO funds to augment growth and innovation. Ultimately, investors must undertake a rigorous analysis of diverse aspects of the company to guarantee a substantial return on their investment.</p><h4>Practice Areas</h4><ul><li>Company acquisition options development</li><li>Portfolio expansion through new product options development</li><li>Spin-off and Joint Venture opportunity development</li></ul>",
      "backgroundColor": "hsl(200, 25%, 30%)"
    }
  ]
}
